36
Participants
Start Date
August 31, 2015
Primary Completion Date
December 31, 2016
Sevacizumab
escalating doses of Sevacizumab : 3mg/kg,4mg/kg,5mg/kg
Irinotecan
Irinotecan: IV solution, IV over 90 minutes, 180 mg/m², Every 14 days, Until disease progression/toxicity
5-FU
5-FU: IV solution, IV bolus over 2-4 minutes, 400 mg/m²; IV infusion over 46 hours, 2400 mg/m²; Every 14 days, Until disease progression/toxicity
Leucovorin
Leucovorin: IV solution, IV over 2 hours, 400 mg/m², Every 14 days, Until disease progression/toxicity
RECRUITING
The First Bethune Hospital of Jilin University, Changchun
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
RECRUITING
The First Hospital of Zhejiang Province, Hangzhou
Lead Sponsor
Jiangsu Simcere Pharmaceutical Co., Ltd.
INDUSTRY